These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 29778284)

  • 1. [Clinical and epidemiological profile of pediatric uveitis, course of inflammatory uveitis treated with anti-TNF alpha].
    Osswald D; Rameau AC; Speeg-Schatz C; Terzic J; Sauer A
    J Fr Ophtalmol; 2018 May; 41(5):447-452. PubMed ID: 29778284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Tumor Necrosis Factor Treatment in the Management of Pediatric Noninfectious Uveitis: Infliximab Versus Adalimumab.
    Ucan Gunduz G; Yalcinbayir O; Cekic S; Yildiz M; Kilic SS
    J Ocul Pharmacol Ther; 2021 May; 37(4):236-240. PubMed ID: 33512278
    [No Abstract]   [Full Text] [Related]  

  • 3. Changing evidence over time: updated meta-analysis regarding anti-TNF efficacy in childhood chronic uveitis.
    Maccora I; Fusco E; Marrani E; Ramanan AV; Simonini G
    Rheumatology (Oxford); 2021 Feb; 60(2):568-587. PubMed ID: 33219694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventive effect of tumor necrosis factor inhibitors versus nonsteroidal anti-inflammatory drugs on uveitis in patients with ankylosing spondylitis.
    Kim MJ; Lee EE; Lee EY; Song YW; Yu HG; Choi Y; Lee EB
    Clin Rheumatol; 2018 Oct; 37(10):2763-2770. PubMed ID: 30076542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term efficacy and tolerability of TNFα inhibitors in the treatment of non-infectious ocular inflammation: an 8-year prospective surveillance study.
    Sharma SM; Damato E; Hinchcliffe AE; Andrews CD; Myint K; Lee R; Dick AD
    Br J Ophthalmol; 2021 Sep; 105(9):1256-1262. PubMed ID: 30862619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timing of infliximab and adalimumab initiation despite methotrexate in children with chronic non-infectious anterior uveitis.
    McCracken C; Yeh S; Jenkins K; Travers C; Stryker D; Tommasello S; Rouster-Stevens KA; Lambert SR; Prahalad S; Drews-Botsch C; Angeles-Han ST
    Eye (Lond); 2019 Apr; 33(4):629-639. PubMed ID: 30487588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of conventional immunosuppressive drugs versus anti-TNF-α agents in non-infectious non-anterior uveitis.
    Leclercq M; Langlois V; Girszyn N; Le Besnerais M; Benhamou Y; Levesque H; Muraine M; Gueudry J
    J Autoimmun; 2020 Sep; 113():102481. PubMed ID: 32586650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current standardized therapeutic approach for uveitis in Japan.
    Maruyama K
    Immunol Med; 2019 Sep; 42(3):124-134. PubMed ID: 31645201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effectiveness of adalimumab treatment for non-infectious uveitis.
    Hasegawa E; Takeda A; Yawata N; Sonoda KH
    Immunol Med; 2019 Jun; 42(2):79-83. PubMed ID: 31315546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The current status of biological treatment for uveitis.
    Gaggiano C; Sota J; Gentileschi S; Caggiano V; Grosso S; Tosi GM; Frediani B; Cantarini L; Fabiani C
    Expert Rev Clin Immunol; 2020 Aug; 16(8):787-811. PubMed ID: 32700605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expert opinion on the use of biological therapy in non-infectious uveitis.
    Touhami S; Diwo E; Sève P; Trad S; Bielefeld P; Sène D; Abad S; Brézin A; Quartier P; Koné Paut I; Weber M; Chiquet C; Errera MH; Sellam J; Cacoub P; Kaplanski G; Kodjikian L; Bodaghi B; Saadoun D
    Expert Opin Biol Ther; 2019 May; 19(5):477-490. PubMed ID: 30888881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of sustained clinical response in patients with Behçet's disease-related uveitis treated with infliximab and adalimumab.
    Fabiani C; Vitale A; Rigante D; Emmi G; Lopalco G; Sota J; Vannozzi L; di Scala G; Guerriero S; Orlando I; Franceschini R; Capozzoli M; Frediani B; Galeazzi M; Iannone F; Tosi GM; Cantarini L
    Clin Rheumatol; 2018 Jun; 37(6):1715-1720. PubMed ID: 29671190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Factors Leading to Anti-TNF Alpha Therapies in Pediatric Severe Uveitis.
    Osswald D; Rameau AC; Terzic J; Sordet C; Bourcier T; Sauer A
    Front Pediatr; 2022; 10():802977. PubMed ID: 35311049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epidemiologic and etiologic patterns of uveitis in a University Hospital].
    Neiter E; Conart JB; Baumann C; Rousseau H; Zuily S; Angioi-Duprez K
    J Fr Ophtalmol; 2019 Oct; 42(8):844-851. PubMed ID: 31164299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunosuppressive therapy in severe or chronic pediatric uveitis: Review of the literature].
    Stolowy N; Zanin E; Comet A; Jurquet AL; Benso C; Matonti F; Retornaz K; Kaplanski G; Denis D
    J Fr Ophtalmol; 2021 Feb; 44(2):252-258. PubMed ID: 33423814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges for further successful development of tumor necrosis factor targeting therapies for uveitis.
    Thng ZX; Regenold J; Bromeo AJ; Akhavanrezayat A; Than NTT; Khatri A; Mohammadi SS; Tran ANT; Shin YU; Karaca I; Ghoraba HH; Or CCM; Nguyen QD
    Expert Opin Investig Drugs; 2024 Feb; 33(2):95-104. PubMed ID: 38299551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-streptococcal uveitis syndrome in a Caucasian population: a case series.
    Curragh DS; McAvoy CE; Rooney M; McLoone E
    Eye (Lond); 2019 Mar; 33(3):380-384. PubMed ID: 30228367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence-Based Treatment for Uveitis.
    Gamalero L; Simonini G; Ferrara G; Polizzi S; Giani T; Cimaz R
    Isr Med Assoc J; 2019 Jul; 21(7):475-479. PubMed ID: 31507124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biologics in the Treatment of Uveitis.
    Dingerkus VLS; Becker MD; Doycheva D
    Klin Monbl Augenheilkd; 2022 May; 239(5):686-694. PubMed ID: 35426112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Knowledge of Biologics in Treatment of Noninfectious Uveitis.
    Gupta S; Shyamsundar K; Agrawal M; Vichare N; Biswas J
    J Ocul Pharmacol Ther; 2022 Apr; 38(3):203-222. PubMed ID: 35133890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.